Get all your news in one place
100’s of premium titles. One news app. Zero ads. Just $10 per month.
Benzinga

Dare Bioscience: Q1 Earnings Insights

 

Dare Bioscience (NASDAQ:DARE) reported its Q1 earnings results on Thursday, May 12, 2022 at 06:00 AM.

Here's what investors need to know about the announcement.

Earnings

Dare Bioscience beat estimated earnings by 28.57%, reporting an EPS of $-0.1 versus an estimate of $-0.14.

Revenue was down $0.00 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.03 which was followed by a 14.77% increase in the share price the next day.

 

To track all earnings releases for Dare Bioscience visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.